HaemAnalytica Showcases Next-Generation Platelet Analysis in Light of Clopidogrel Effectiveness Study
HaemAnalytica shared a noteworthy post on LinkedIn:
“It’s September, holidays are over and blood thinners are in the news! A new study has shown that clopidogrel is a more effective blood thinner than aspirin.
Our CSO, Jon Gibbins said “The impact of clopidogrel monotherapy on improved patient outcomes is very encouraging. This will improve the options available to prevent the recurrence of thrombosis. The final piece in the puzzle to provide a step-change, will be the stratification of patients – to identify which need monotherapy, which require dual anti-platelet therapy, and which are at most risk of serious bleeding side effects. This is HaemAnalytica’s mission.’”
Read the Lancet study on clopidogrel effectiveness here.
Article: Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
Authors: Marco Valgimigli, Ki Hong Choi, Daniele Giacoppo, Felice Gragnano, Takeshi Kimura, Hirotoshi Watanabe, Hyo-Soo Kim, Jeehoon Kang, Kyung Woo Park, Alf-Åge Pettersen, Mark Woodward, Deepak L Bhatt, Paolo Calabrò, Dominick J Angiolillo, Roxana Mehran, Young Bin Song, Joo-Yong Hahn
Find more on HaemAnalytica next generation platelet analysis here.
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 12:57Ali AlBahar: DNA Drives the Molecular Era of Blood Typing
-
Apr 22, 2026, 11:47We Are Excited to Introduce You to the 11th Editor-in-Chief Dr. Bob Löwenberg – Blood Journals Portfolio
-
Apr 22, 2026, 11:35Congratulations to Donald Arnold for Being Recognized with The ISTH 2026 Harold R. Roberts Award
-
Apr 22, 2026, 11:27Prashasti Dahiya: Key Molecular Insights on Thromboinflammation and Angiogenesis in Pediatric Cancer
-
Apr 22, 2026, 11:17Jack Hadfield: Understanding the Immune and Genetic Basis of VITT Post-COVID Vaccines
-
Apr 22, 2026, 07:56Shruti Kharat: Closing the Gap in Early Detection of Factor VIII Inhibitors
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61